<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Asrress KN</submitter><funding>British Heart Foundation</funding><pagination>24-34</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5491223</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>136(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The mechanisms governing exercise-induced angina and its alleviation by the most commonly used antianginal drug, nitroglycerin, are incompletely understood. The purpose of this study was to develop a method by which the effects of antianginal drugs could be evaluated invasively during physiological exercise to gain further understanding of the clinical impact of angina and nitroglycerin.&lt;h4>Methods&lt;/h4>Forty patients (mean age, 65.2±7.6 years) with exertional angina and coronary artery disease underwent cardiac catheterization via radial access and performed incremental exercise using a supine cycle ergometer. As they developed limiting angina, sublingual nitroglycerin was administered to half the patients, and all patients continued to exercise for 2 minutes at the same</pubmed_abstract><journal>Circulation</journal><pubmed_title>Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise.</pubmed_title><pmcid>PMC5491223</pmcid><funding_grant_id>FS/11/90/29087</funding_grant_id><funding_grant_id>FS/11/43/28760</funding_grant_id><funding_grant_id>FS/14/11/30526</funding_grant_id><funding_grant_id>FS/13/15/30026</funding_grant_id><funding_grant_id>CS/16/3/32615</funding_grant_id><funding_grant_id>FS/12/15/29380</funding_grant_id><funding_grant_id>FS/10/62/28409</funding_grant_id><pubmed_authors>Asrress KN</pubmed_authors><pubmed_authors>Clapp B</pubmed_authors><pubmed_authors>Chowienczyk PJ</pubmed_authors><pubmed_authors>Lockie T</pubmed_authors><pubmed_authors>Ellis H</pubmed_authors><pubmed_authors>De Silva K</pubmed_authors><pubmed_authors>Patterson T</pubmed_authors><pubmed_authors>Redwood SR</pubmed_authors><pubmed_authors>Ihsan S</pubmed_authors><pubmed_authors>Khawaja MZ</pubmed_authors><pubmed_authors>Marber MS</pubmed_authors><pubmed_authors>Perera D</pubmed_authors><pubmed_authors>Lumley M</pubmed_authors><pubmed_authors>Arri S</pubmed_authors><pubmed_authors>Guilcher A</pubmed_authors><pubmed_authors>Williams R</pubmed_authors><pubmed_authors>Plein S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise.</name><description>&lt;h4>Background&lt;/h4>The mechanisms governing exercise-induced angina and its alleviation by the most commonly used antianginal drug, nitroglycerin, are incompletely understood. The purpose of this study was to develop a method by which the effects of antianginal drugs could be evaluated invasively during physiological exercise to gain further understanding of the clinical impact of angina and nitroglycerin.&lt;h4>Methods&lt;/h4>Forty patients (mean age, 65.2±7.6 years) with exertional angina and coronary artery disease underwent cardiac catheterization via radial access and performed incremental exercise using a supine cycle ergometer. As they developed limiting angina, sublingual nitroglycerin was administered to half the patients, and all patients continued to exercise for 2 minutes at the same</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jul</publication><modification>2026-06-11T05:44:11.112Z</modification><creation>2026-06-11T03:08:41.96Z</creation></dates><accession>S-EPMC5491223</accession><cross_references><pubmed>28468975</pubmed><doi>10.1161/CIRCULATIONAHA.116.025856</doi></cross_references></HashMap>